INDEMNIFICATION AGREEMENTIndemnification Agreement • September 21st, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of __________ by and between ENDRA Inc., a Delaware corporation (the “Company”), and ________________ (“Indemnitee”).
Endra, Inc. SUBSCRIPTION AGREEMENTSubscription Agreement • September 21st, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus • California
WARRANT TO PURCHASE COMMON STOCK OF ENDRA, INC.Warrant Agreement • September 21st, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus • California
This certifies that __________________, or assigns (collectively, the “Holder”), for value received, is entitled to purchase, at an exercise price per share equal to $_____ (the “Exercise Price”), from ENDRA, INC., a Delaware corporation (the “Company”), up to ____________ (_________) fully paid and nonassessable shares of the Company’s Common Stock (the “Common Stock”). This Warrant shall be exercisable at any time from time to time from and after the date of issuance hereof (the “Issuance Date”) up to and including 5:00 p.m. (Pacific Time) on the first to occur of (i) the second (2nd) anniversary of the Issuance Date or (ii) on the closing date of a financing transaction resulting in the Company receiving gross proceeds of at least $5.0 million at a valuation, calculated prior to the date of consummation of the financing, of at least $10.0 million (a “Qualified Financing”) (such earlier date being referred to herein as the “Expiration Date”), upon surrender to the Company at its prin
EXCHANGE AGREEMENTExchange Agreement • September 21st, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This Agreement (“Agreement”) is entered into as of September __, 2014, by and between Endra, Inc., a Delaware corporation (the “Company”), and ______________ (the “Investor”).
SUBLICENSE AGREEMENTSublicense Agreement • September 21st, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus • Massachusetts
This Sublicense Agreement (“Agreement”) is entered as of the 2nd day of August, 2007 (“Effective Date”) by and between Optosonics, Inc. (“Optosonics”), a Delaware Corporation, with a place of business at 351 West 10th Street, Suite 250, Indianapolis, Indiana and Endra, Inc. (“Endra”), a Massachusetts corporation with a place of business at 222 Berkeley Street, Boston, Massachusetts 02116.
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • September 21st, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus • New York
THIS AGREEMENT is made as of April 22, 2016 (“Effective Date”) by and between General Electric Company, acting through its GE Healthcare business and Global Research unit (“GE”), and ENDRA Inc. a Delaware corporation having its principal place of business at Ann Arbor, MI (“ENDRA”).
ANN ARBOR, MICHIGAN GROSS LEASEGross Lease • September 21st, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus • Michigan
This Lease is made between Landlord and Tenant hereinafter identified in Sections 1(b) and 1(c) hereof, respectively, and constitutes a Lease between the parties of the “Demised Premises” in the “Building,” as defined in Sections 2.2 and 2.1 hereof, respectively, on the terms and conditions and with and subject to the covenants and agreements of the parties hereinafter set forth.
CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • September 21st, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 21st, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus • California
This Securities Purchase Agreement (this “Agreement”), dated as of July 10, 2013, is by and between Enlight Biosciences, LLC, a Delaware limited liability corporation (the “Seller”), and each purchaser identified on Schedule A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
